NeuroPace, Inc.
$15.95
The Read: 9% move on the IGE approval, while its June 15 earnings catalysts have triggered both strong rallies on positive guidance and sharp 18% sell-the-news drops despite beats.
Price
Overlays
Panel
NPCE
Hover to view data
No Data